UY31264A1 - Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en la terapéutica - Google Patents
Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en la terapéuticaInfo
- Publication number
- UY31264A1 UY31264A1 UY31264A UY31264A UY31264A1 UY 31264 A1 UY31264 A1 UY 31264A1 UY 31264 A UY31264 A UY 31264A UY 31264 A UY31264 A UY 31264A UY 31264 A1 UY31264 A1 UY 31264A1
- Authority
- UY
- Uruguay
- Prior art keywords
- disorders
- therapeutics
- derivatives
- preparation
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Derivados de N-heteroaril-carboxamidas tricíclicas de formula general (I), que presentan una actividad antagonista in vitro e in vivo por los receptroes de tipo TRPV1 (o VR1), donde los sustituyentes son tales como se han especificado en la Memoria Descriptiva y en las reivindicaciones correspondientes. Procedimiento de preparacion y aplicacion en terapéutica. Mediacamento destinado a prevenir o tratar el dolor, inflamacion, trastornos metabolicos, trastornos urologicos, trastornos ginecologicos, trastornos gastrointestinales, trastornos respiratorios, psoriasis, pruritos, irritaciones dérmicas, de los ojos o de las mucosas, herpes, zona, depresion, enfermedades del sistema nervioso central.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705677A FR2919610B1 (fr) | 2007-08-02 | 2007-08-02 | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31264A1 true UY31264A1 (es) | 2009-03-02 |
Family
ID=39185736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY31264A UY31264A1 (es) | 2007-08-02 | 2008-08-01 | Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en la terapéutica |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8153796B2 (es) |
| EP (1) | EP2185558B1 (es) |
| JP (1) | JP5259713B2 (es) |
| KR (1) | KR20100041804A (es) |
| CN (1) | CN101772499B (es) |
| AR (1) | AR067754A1 (es) |
| AU (1) | AU2008313601B2 (es) |
| BR (1) | BRPI0814756A2 (es) |
| CA (1) | CA2694994C (es) |
| CL (1) | CL2008002289A1 (es) |
| CO (1) | CO6251362A2 (es) |
| EA (1) | EA017808B1 (es) |
| FR (1) | FR2919610B1 (es) |
| MA (1) | MA31687B1 (es) |
| MX (1) | MX2010001238A (es) |
| MY (1) | MY150428A (es) |
| NZ (1) | NZ582970A (es) |
| PA (1) | PA8790901A1 (es) |
| PE (1) | PE20090565A1 (es) |
| SG (1) | SG183080A1 (es) |
| TW (1) | TWI366566B (es) |
| UY (1) | UY31264A1 (es) |
| WO (1) | WO2009050348A1 (es) |
| ZA (1) | ZA201000745B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201707469WA (en) * | 2015-03-18 | 2017-10-30 | Bristol Myers Squibb Co | Substituted tricyclic heterocyclic compounds |
| TWI698602B (zh) | 2015-07-09 | 2020-07-11 | 美商威士塔戴爾泰克有限責任公司 | 閥之控制板 |
| MX382156B (es) | 2015-08-28 | 2025-03-13 | Chdi Foundation Inc | Sondas para formar imagenes de proteina de huntingtina. |
| WO2022111473A1 (en) * | 2020-11-26 | 2022-06-02 | Bioardis Llc | Compounds as mrgprx2 antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0156327B1 (ko) * | 1995-07-12 | 1998-11-16 | 김종인 | 벤즈 또는 피리도이미다졸 유도체 |
| US6313242B1 (en) * | 1996-05-20 | 2001-11-06 | Fina Technology, Inc. | Stereorigid bis-fluorenyl metallocenes |
| US5708187A (en) * | 1996-06-27 | 1998-01-13 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists |
| ES2337254T3 (es) * | 2003-02-14 | 2010-04-22 | Glaxo Group Limited | Derivados de carboxamida. |
| JP2006526660A (ja) * | 2003-06-05 | 2006-11-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｖｒ１レセプターのモジュレーター |
| GB0319151D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
| FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2897061B1 (fr) * | 2006-02-03 | 2010-09-03 | Sanofi Aventis | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique. |
-
2007
- 2007-08-02 FR FR0705677A patent/FR2919610B1/fr active Active
-
2008
- 2008-07-29 PA PA20088790901A patent/PA8790901A1/es unknown
- 2008-07-30 TW TW097128801A patent/TWI366566B/zh not_active IP Right Cessation
- 2008-07-31 NZ NZ582970A patent/NZ582970A/en not_active IP Right Cessation
- 2008-07-31 AR ARP080103318A patent/AR067754A1/es not_active Application Discontinuation
- 2008-07-31 MX MX2010001238A patent/MX2010001238A/es active IP Right Grant
- 2008-07-31 EP EP08839139.6A patent/EP2185558B1/fr active Active
- 2008-07-31 CN CN2008801014470A patent/CN101772499B/zh not_active Expired - Fee Related
- 2008-07-31 EA EA201070217A patent/EA017808B1/ru not_active IP Right Cessation
- 2008-07-31 KR KR1020107002302A patent/KR20100041804A/ko not_active Ceased
- 2008-07-31 JP JP2010518710A patent/JP5259713B2/ja not_active Expired - Fee Related
- 2008-07-31 SG SG2012055265A patent/SG183080A1/en unknown
- 2008-07-31 BR BRPI0814756A patent/BRPI0814756A2/pt not_active IP Right Cessation
- 2008-07-31 AU AU2008313601A patent/AU2008313601B2/en not_active Ceased
- 2008-07-31 PE PE2008001286A patent/PE20090565A1/es not_active Application Discontinuation
- 2008-07-31 CA CA2694994A patent/CA2694994C/fr not_active Expired - Fee Related
- 2008-07-31 WO PCT/FR2008/001141 patent/WO2009050348A1/fr not_active Ceased
- 2008-07-31 MY MYPI20100448 patent/MY150428A/en unknown
- 2008-08-01 UY UY31264A patent/UY31264A1/es not_active Application Discontinuation
- 2008-08-01 CL CL2008002289A patent/CL2008002289A1/es unknown
-
2010
- 2010-01-29 US US12/696,149 patent/US8153796B2/en not_active Expired - Fee Related
- 2010-02-01 CO CO10010102A patent/CO6251362A2/es active IP Right Grant
- 2010-02-01 ZA ZA2010/00745A patent/ZA201000745B/en unknown
- 2010-03-01 MA MA32663A patent/MA31687B1/fr unknown
-
2012
- 2012-03-06 US US13/412,855 patent/US8420817B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30518A1 (es) | Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas, su preparacion y su aplicacion en terapéutica | |
| CL2009000120A1 (es) | Compuestos derivados de carboxamidas n-aza-biciclicas; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y su uso como antagonistas o agonistas del receptor tipo trpv1 para tratar el dolor, la inflamacion, trastornos metabolicos, urologicos, ginecologicos, gastrointestinales, respiratorios. | |
| CL2012001673A1 (es) | Compuestos derivados de benzamida sustituidos, como moduladores de taar; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de la depresión, trastornos de ansiedad, trastorno bipolar, esquizofrenia, epilepsia, migraña, enfermedad de alzheimer, trastornos metabolicos, entre otras. | |
| ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
| GT201400222A (es) | Agentes para tratar trastornos que implican la modulación de receptores de rianodina | |
| UY31405A1 (es) | "piperidino-dihidrotienopirimidas sustituidas" | |
| UY33277A (es) | Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso | |
| CR20190073A (es) | FORMAS DE DOSIFICACIÓN DE RUXOLITINIB DE LIBERACIÓN SOTENIDA (Divisional 2015-265) | |
| CL2009000445A1 (es) | Compuestos derivados de piperidina 1,4 heterociclo sustituidos, procedimiento para preparar estos compuestos, composicion farmaceutica que los comprende y su uso para la terapia del dolor y el tratamiento de enfermedades como alzheimer, esquizofrenia, ansiedad y depresion. | |
| CR11095A (es) | Compuestos amino-heterociclicos | |
| ECSP12012065A (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos | |
| GT201200201A (es) | Moduladores alostéricos positivos de receptores m1 de la quinolina amida | |
| UY33029A (es) | Antagonistas de espiro-oxindol de mdm2 | |
| MX2015011448A (es) | Compuestos y sus usos para modular la hemoglobina. | |
| MX2015011769A (es) | Compuestos y sus usos para modular la hemoglobina. | |
| DOP2009000190A (es) | Compuestos triciclicos y su uso como moduladores de receptor de glucocorticoides | |
| UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
| CR8718A (es) | Compuesto de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central | |
| MX2020005736A (es) | Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida. | |
| PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| CL2011001428A1 (es) | Compuestos derivados de amidas del acido tetrahidroisoquinolil-4-oxobutirico; composicion farmaceutica; y uso en el tratamiento de desordenes o enfermedades mediadas por canales de potasio kcnq2/3, tales como dolor, epilepsia. incontinencia urinaria, ansiedad, entre otras. | |
| UY30625A1 (es) | Piridinonas antagonistas del receptor-1 de la hormona concentradora de melanina | |
| UY32051A (es) | Compuestos de azetidinas polisustituidos, su preparación y su aplicación en terapéutica | |
| UY37947A (es) | Amidas de imidazopiridina sustituidas y su uso | |
| UY31264A1 (es) | Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en la terapéutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20140729 |